619 Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy

• Taha Merghoub,
• Sadna Budhu,
• Roberta Zappasodi,
• Levi Mangarin,
• Svena Verma,
• Inna Serganova,
• Rachana Maniyar,
• Ronald Blasberg,
• Myat Ko

Affiliations

Taha Merghoub

1Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Sadna Budhu

1MSKCC, New York, NY, USA

Roberta Zappasodi

Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Levi Mangarin

1Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Svena Verma

1Memorial Sloan Kettering Cancer Center, New York, NY, USA

Inna Serganova

1Memorial Sloan Kettering Cancer Center, New York, USA

Rachana Maniyar

1Memorial Sloan Kettering Cancer Center, New York, USA

Ronald Blasberg

1Memorial Sloan Kettering Cancer Center, New York, USA

Myat Ko

1Memorial Sloan Kettering, New York, NY, USA